Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (stock code: 00874) disclosed its January 2026 Monthly Return on Movements in Securities. The total authorized and registered share capital remained at RMB 1,625,790,949, comprising 219,900,000 H shares and 1,405,890,949 A shares, both with a par value of RMB 1. No adjustments were made during the reporting period, leaving the company’s share structure unchanged.

The number of issued H shares stood at 219,900,000, while the number of issued A shares was 1,405,890,949. There were no treasury shares and no relevant share options, warrants, or convertible securities recorded. The filing confirms compliance with the 5% minimum public float requirement for H shares. No new share movements were reported, and the company complied with the applicable listing rules and regulatory requirements throughout the reporting period.